Previous 10 | Next 10 |
home / stock / ogi / ogi articles
Cannabis And Hemp Regulatory Appointments Last week, Flora Growth Corp. (NASDAQ:FLGC) announced that Clifford Starke, its CEO and director, has bee...
A group of Canadian cannabis producers found themselves in hot water after the commissioner of Israel’s Trade Levies Unit launched an "anti-d...
Even though the European cannabis scene has not yet witnessed unexpected large-scale shifts, markets like the U.K., Germany, Denmark, Portugal and ...
Indigenous Leaders Lead The Way In Cannabis Regulation The Indigenous Cannabis Industry Association (ICIA) recently hosted its first Indigenous Can...
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) reported on Tuesday its fourth quarter financial results for the three months ended Sept. 30., reve...
With a nearly 50% share in infused pre-rolls, which constitute 70% of its sales, Decibel Cannabis Co. Inc. (TSXV: DB) (OTC: DBCCF) is well-pos...
Zuanic & Associates has initiated coverage on Village Farms International (NASDAQ: VFF), assigning an "Overweight" rating. What are t...
Five years into its legalization, the Canadian cannabis market reveals intriguing regional disparities and growth trends, as highlighted in the lat...
German lawmakers are expecting a recently revised version of the marijuana legalization measure to bring about the long-awaited policy change in th...
News, Short Squeeze, Breakout and More Instantly...
Organigram Holdings Inc. Company Name:
OGI Stock Symbol:
NYSE Market:
Organigram Holdings Inc. Website:
Second “Jupiter” investment strengthens Organigram’s European access, including to the high-growth market of Germany Highlights: Concurrent to the investment, Organigram and Sanity Group have entered into a new supply agreement to include significantly higher ...
Over a three-year period, Organigram expects to supply 1,700 kilograms of high-quality medical cannabis flower to Avida Medical, with 500 kilograms expected to be delivered in the first year of the agreement. Avida Medical to become Organigram’s second international medical cannabis cu...